Board of Directors

The Society of Future Nurse Anesthetists is privileged to be supported by a Board of Directors comprised of distinguished members from the business, healthcare, and education sectors. These dedicated individuals are deeply committed to our mission of empowering aspiring nurse anesthetists through comprehensive education, mentorship, and resource provision.

Our Board of Directors plays a crucial role in maintaining the vitality and sustainability of SFNA’s initiatives. They provide strategic guidance that aligns with our core purpose and effectively responds to the evolving needs of our community and members. Through their stewardship, SFNA will advance in its commitment to enhance the professional growth and success of those desiring to fulfill their goal as Certified Registered Nurse Anesthetists.

Board Member Bios

Kiki Mattress — President & Founder

Certified Registered Nurse Anesthetist (CRNA) and healthcare entrepreneur with a foundation spanning critical care nursing, anesthesia practice, and advanced clinical leadership across high-acuity surgical and ICU environments.
Founder & President of the Society of Future Nurse Anesthetists (SFNA), a national nonprofit dedicated to mentorship, education, and expanding access and opportunity for aspiring CRNAs through programs, events, and strategic partnerships.
Proven leader in building and scaling mission-driven initiatives, developing educational programs, professional development pathways, and community-based experiences that support career advancement in healthcare.
Extensive clinical expertise in anesthesia delivery, perioperative care, and critical care management, with a strong focus on patient safety, multimodal pain strategies, and optimized recovery outcomes.
Experienced speaker and educator, delivering clinical and professional development content on topics including emergency response, capnography, surgical safety, and healthcare systems improvement.
Brings to SFNA a unique combination of clinical excellence, entrepreneurial vision, and community leadership, driving initiatives that empower the next generation of nurse anesthetists to build careers, confidence, and long-term impact.

Henry Hagopian, III — Board Treasurer

Seasoned finance executive and strategic advisor with extensive experience operating at the C-suite and Board level across biotech, healthcare, technology, and industrial sectors, with deep expertise in financial strategy, capital markets, and global operations.
Former Chief Financial Officer of a publicly traded biopharma company (NYSE), serving as a key partner to the CEO and Board in shaping corporate strategy, financial planning, investor relations, and long-term growth initiatives.
Proven leader in capital strategy and financial execution, including securing and managing large-scale financing initiatives (credit facilities, equity offerings), supporting IPO readiness, and driving significant increases in market capitalization.
Deep expertise in corporate finance operations, including treasury, FP&A, risk management, SEC reporting, and global financial systems, with a track record of building scalable financial infrastructure and ensuring regulatory compliance.
Experienced in mergers, acquisitions, and corporate restructuring, with a strong ability to lead due diligence, integrate systems, and align financial strategy with operational growth across complex organizations.
Brings to SFNA a high-level financial and strategic lens, supporting sustainable growth, partnership development, and long-term organizational scalability to expand access and opportunity for future CRNAs.

Ken Shaw — Board Secretary

Visionary C-level healthcare and MedTech executive with 25+ years of experience leading high-growth, multi-market organizations, known for driving large-scale transformation, operational excellence, and sustained revenue expansion across global markets.
President & CEO of Nanosonics North America, leading the company’s largest and most critical subsidiary (~91% of global revenue), overseeing multi-country operations (U.S., Canada, Mexico) and a 150+ cross-functional team across commercial, clinical, technical, and operational divisions.
Demonstrated track record of delivering exceptional financial performance, achieving double-digit revenue growth (18–24% CAGR) and nearly 50% EBITDA growth, while scaling innovative recurring revenue streams through IoT/SaaS and annuity-based business models.
Elite turnaround and growth strategist, with a proven ability to reverse declining performance, restructure complex organizations, and reposition brands through customer-centric, data-driven, and market-aligned strategies.
Deep expertise across enterprise growth levers including B2B, B2C, and DTC commercial strategy, M&A, go-to-market execution, and cross-functional leadership, with a history of building high-performing teams and scalable systems across healthcare and global consumer sectors.
Brings to SFNA a powerful combination of executive leadership, strategic vision, and partnership development expertise, supporting organizational scale, revenue growth, and expanded access and opportunity for the next generation of CRNAs.

Nzinga Lowe — Board Member

Accomplished global healthcare advisor, clinical executive, and health equity leader with deep expertise across value-based care, population health, clinical operations, and large-scale healthcare transformation.
Founder & CEO of Pygmalion Health, a healthcare advisory firm driving strategic outcomes for medical practices through enhanced payer relationships, operational efficiency, and performance-based care models.
Leads multi-state and national clinical operations initiatives, including development of health equity strategies, EMR connectivity solutions, and scalable frameworks that improve quality metrics and system-wide performance.
Demonstrated track record of accelerating organizational performance, including significant improvements in HEDIS STAR ratings, quality gap closure, and patient outcomes through data-driven clinical workflows and provider education.
International speaker and industry thought leader recognized for advancing health equity, building high-impact partnerships, and educating healthcare leaders on sustainable, performance-driven care models for underserved populations.
Supports SFNA with a mission-aligned focus on healthcare innovation, strategic partnerships, and expanding equitable access, leadership pathways, and long-term success for future nurse anesthetists.

Bryan Woodyard — Board Member

Accomplished business development and strategic growth leader with more than three decades of experience spanning strategy, communication, technology, operational execution, and market-facing leadership.
He is the Partner/CRO/CSO of healthcare innovation within an anesthesia-focused digital transformation platform Q, where he leads & supports strategic growth, technology innovation, and industry alignment.
Bryan currently serves multiple healthcare organizations, contributing executive-level leadership in strategic planning, visibility, and organizational momentum.
He has led key initiatives within the IQVIA clinical trial organization, Microsoft for Startups, Founder Institute, General Mills Corporation, and VA & FHA, where his roles spanned technology implementation, logistics coordination, strategic operations, client liaison positioning, and GTM strategy/funding.
As board member, advisor, strategic thinker, innovator, and Founder Institute alum, he has defined his career through growth-stage problem solving and partnership development.
Supports SFNA with a mission-aligned perspective on healthcare advancement, technology initiatives, relationship building, and the expansion of access, opportunity, and leadership pathways for aspiring CRNAs.